MLchartDataset catalogue

DHAP regimen

Term · Oncology and biomedicine · MLC-T-ONC-013023

A chemotherapy regimen consisting of dexamethasone, high-dose cytarabine (ARA-C) and cisplatin (Platinol), used for the treatment of relapsed and refractory Hodgkin and non-Hodgkin lymphomas.

Table 1. Record
IdentifierMLC-T-ONC-013023
FieldOncology and biomedicine
SynonymsDexamethasone-High-dose-Ara-C-cis-Platin
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON 
{
  "id": "MLC-T-ONC-013023",
  "term": "DHAP regimen",
  "field": "Oncology and biomedicine",
  "definition": "A chemotherapy regimen consisting of dexamethasone, high-dose cytarabine (ARA-C) and cisplatin (Platinol), used for the treatment of relapsed and refractory Hodgkin and non-Hodgkin lymphomas.",
  "synonyms": [
    "Dexamethasone-High-dose-Ara-C-cis-Platin"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/dhap-regimen/"
}

Record 5,912 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.